Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
Medtronic has entered into a definitive agreement to acquire Scientia Vascular, a neurovascular device company, for $550 million, according to a March 10 news release. Scientia Vascular, based in Salt Lake City, has about 300 employees. “Scientia’s portfolio of guidewires…
President Donald Trump’s new 10% global tariff is adding another layer of uncertainty to hospital supply chains, prompting leaders to revisit sourcing strategies, reinforce pricing protections and reassess contingency plans for critical medical products. The tariff was imposed less than…
Medline Industries has expanded a previous recall of certain reprocessed electrophysiology and ultrasound catheters due to the potential presence of small residual particulates that could lead to infection, embolism, or thrombosis. The latest list of affected devices, which are used…
Hospitals have spent decades modernizing their most visible operational systems — electronic medical records, enterprise resource planning platforms, group purchasing strategies. Yet one of the most complex and costly operational ecosystems inside a health system remains largely fragmented: vendor operations.…
Medline has begun piloting its AI-powered supply chain platform, Mpower, with 10 health systems in the U.S. Built in collaboration with Microsoft, Mpower is a cloud-based “digital control tower.”. The platform uses real-time data and predictive analytics to help providers…
Fresenius Kabi has issued a software correction for its Ivenix large-volume pump after identifying anomalies that could cause therapy interruptions or delays. The update affects Ivenix pump software version 5.10.1 and earlier. On Feb. 25, the FDA classified the action…
Ochsner Health in New Orleans has named Mark French chief supply chain officer. Mr. French most recently served as Ochsner’s COO of supply chain and support services from December 2022 to February 2026. He previously held the role of vice…
The FDA has classified Boston Scientific’s removal of certain Axios Stent and Electrocautery-Enhanced Delivery Systems as a Class I recall, the agency’s most serious designation. The recall stems from increased reports of deployment and expansion issues during stent placement. As…
Vice President JD Vance and CMS Administrator Mehmet Oz, MD, announced a series of actions affecting Medicare and Medicaid, including a $259.5 million deferral of federal Medicaid funding in Minnesota and a six-month moratorium on new Medicare enrollment for certain…
The FDA has issued an early alert regarding certain Abiomed Impella system components after the company recommended removing specific products from use because of an increased risk of purge leaks. In a Feb. 18 letter to customers, Abiomed said it…